Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
Tech
Science

Celltrion
Biotech
Topics

Advertisement

Celltrion

Share

Top Latest Popular

Thursday

Labor disputes emerge as new risk for Samsung Biologics, Celltrion The Korea Herald 03:24 Thu, 11 Jun

Wednesday

Celltrion picks AI, organoid startups for latest open innovation program Korea Biomedical Review 07:09 Wed, 10 Jun

Monday

Spotlight On: Herceptin® (trastuzumab) / Ogivri® (trastuzumab-dkst) / Herzuma® (trastuzumab-pkrb) / Ontruzant® (trastuzumab-dttb)... JD Supra 16:51 Mon, 08 Jun

Advertisement

Advertisement

In the last month

Spotlight On: Rituxan® (rituximab) / Truxima® (rituximab-abbs) / Ruxience® (rituximab-pvvr) / Riabni™ (rituximab-arrx) - June 2026 JD Supra 19:15 Fri, 05 Jun

Spotlight On: Biosimilar Litigations - June 2026 JD Supra 17:33 Fri, 05 Jun

Celltrion workers establish company's first labor union, demand compensation transparency Korea JoongAng Daily 11:05 Mon, 01 Jun

Celltrion files for approval of Cosentyx biosimilar, CT-P55, in Canada Korea Biomedical Review 07:57 Mon, 01 Jun

Workers at Celltrion launch first union in company's history Yonhap News Agency 06:53 Mon, 01 Jun

Celltrion develops quadruple-action obesity drug Miami Herald 12:50 Fri, 29 May

Celltrion pushes beyond GLP-1 with next-generation obesity drug The Korea Herald 06:56 Fri, 29 May

Celltrion begins final preclinical studies for obesity drug CT-G32 Korea Biomedical Review 06:34 Fri, 29 May

Celltrion to issue bonus shares, repurchase stocks to boost shareholder value Yonhap News Agency 07:21 Thu, 21 May

Celltrion’s Vegzelma strengthens lead in Japan bevacizumab biosimilar market Korea Biomedical Review 05:53 Mon, 18 May

Analysts grow more bullish on Celltrion as margin expansion gains traction Korea Biomedical Review 01:08 Thu, 14 May

Advertisement

Advertisement

About our Celltrion news

Latest news on Celltrion, a biopharmaceutical company headquartered in Incheon, South Korea.

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Business Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna